Drug Discovery and Development Analysis & Statistics in the United States, December 2014

24/7 Customer Support

Talk to Louis

+1 718 618 4302

Publishers

  • All
    • GBI Research

All regions

data types

You might be interested in: Clinical Trial, Drug Discovery, Drug Development, more »

1-7 of 7 reports

Purchase Reports From Reputable Market Research Publishers

Engaging Key Opinion Leaders (KOLs) - Identifying and Leveraging New KOL Groups to Drive Medical Marketing Strategy

Engaging Key Opinion Leaders (KOLs) - Identifying and Leveraging New KOL Groups to Drive Medical Marketing Strategy

  • $ 3 500
  • Industry report
  • September 2012
  • by GBI Research

Engaging Key Opinion Leaders (KOLs) - Identifying and Leveraging New KOL Groups to Drive Medical Marketing Strategy Summary GBI Research, the leading business intelligence provider, has released its ...

  • Industries : Drug Discovery and Development
  • Countries : United States
Pathways to Efficient Drug Development - Advances in Modeling and Simulation Outcomes to Fuel Pipeline Productivity

Pathways to Efficient Drug Development - Advances in Modeling and Simulation Outcomes to Fuel Pipeline Productivity

  • $ 3 500
  • Industry report
  • September 2012
  • by GBI Research

Pathways to Efficient Drug Development - Advances in Modeling and Simulation Outcomes to Fuel Pipeline Productivity Summary GBI Research, the leading business intelligence provider, has released its ...

  • Industries : Drug Discovery and Development
  • Countries : United States
Workforce Reductions in Pharmaceuticals - Outsourcing, External Innovation and Collaboration Will Drive the Industry Forward

Workforce Reductions in Pharmaceuticals - Outsourcing, External Innovation and Collaboration Will Drive the Industry Forward

  • $ 3 500
  • Industry report
  • June 2012
  • by GBI Research

Workforce Reductions in Pharmaceuticals - Outsourcing, External Innovation and Collaboration Will Drive the Industry Forward Summary GBI Research, the leading business intelligence provider, has released ...

  • Industries : Drug Discovery and Development
  • Countries : United States
Patient Perspectives - Patient Reported Outcomes Drive Drug Development, but Improving Patient Involvement Remains a Challenge

Patient Perspectives - Patient Reported Outcomes Drive Drug Development, but Improving Patient Involvement Remains a Challenge

  • $ 3 500
  • Industry report
  • May 2012
  • by GBI Research

Patient Perspectives - Patient Reported Outcomes Drive Drug Development, but Improving Patient Involvement Remains a Challenge Summary GBI Research, the leading business intelligence provider, has released ...

  • Industries : Drug Discovery and Development
  • Countries : United States
Post Marketing Clinical Research - REMS, the Latest Reformation due to Post Marketing Surveillance to Enhance Patient Compliance

Post Marketing Clinical Research - REMS, the Latest Reformation due to Post Marketing Surveillance to Enhance Patient Compliance

  • $ 3 500
  • Industry report
  • September 2011
  • by GBI Research

Post Marketing Clinical Research - REMS, the Latest Reformation due to Post Marketing Surveillance to Enhance Patient Compliance Summary GBI Research has released its latest report, ?Post Marketing Clinical ...

  • Industries : Drug Discovery and Development
  • Countries : United States, Japan, Europe, World
Lifesciences IT - 2011 Yearbook

Lifesciences IT - 2011 Yearbook

  • $ 3 500
  • Industry report
  • June 2011
  • by GBI Research

Lifesciences IT - 2011 Yearbook Summary GBI Research's research, ?Lifesciences IT - 2011 Yearbook" provides key data, information and analysis on Lifesciences \IT that is being implemented by pharmaceutical ...

  • Industries : Drug Discovery and Development
  • Countries : United States, India, World
Preclinical Models - Preclinical CROs will Continue to Improve the Quality and Accuracy of Data for Targeted Therapies

Preclinical Models - Preclinical CROs will Continue to Improve the Quality and Accuracy of Data for Targeted Therapies

  • $ 3 500
  • Industry report
  • March 2011
  • by GBI Research

Preclinical Models - Preclinical CROs will Continue to Improve the Quality and Accuracy of Data for Targeted Therapies Summary GBI Research, the leading business intelligence provider, has released its ...

  • Industries : Drug Discovery and Development
  • Countries : World, United States, Europe, Switzerland, Sweden, Spain, Italy, France, Germany, Denmark, Belgium, Canada



ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.